As shown in Figure 9D–F, MAPK4 expression was significantly positively correlated with expression of the main immunoinhibitory checkpoint molecules PD‐1, PD‐L1, HAVCR2, PDCD1LG2 and TIGIT in glioma. This evidence concerns the gene PDCD1LG2 and central nervous system cancer.